Kriya Therapeutics
Business Services · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4105 Hopson Rd, Morrisville, North Carol...Phone Number
(833) 574-9289Website
www.kriyatherapeutics.comRevenue
$42.3 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
3
1
1
2
2
About Kriya Therapeutics
Kriya Therapeutics is a biopharmaceutical company focused on research and development of innovative gene therapies for prevalent diseases, supported by an in-house manufacturing facility to ensure scalable and cost-effective production.Explore more
Kriya Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kriya Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kriya Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Kriya Therapeutics
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Kriya Therapeutics launches new products
Check if Kriya Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Kriya Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Kriya Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Kriya Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Kriya Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Kriya Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Kriya Therapeutics
Compare insights from companies similar to Kriya Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kriya Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kriya Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kriya Therapeutics.
Kriya Therapeutics financials insights
Gather financial insights about Kriya Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$80.5M
2021
Series B
$100M
2023
Series C
$430M
2025
Stock/Share Issuance
$313.3M
Series D
$313.3M
Kriya Therapeutics Tech Stack
A closer look at the technologies used by Kriya Therapeutics
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Hiring Plans
Kriya Therapeutics has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Pharmaceuticals, Manufacturing Operations
Kriya Therapeutics News & Media
Kriya Appoints Sachiyo Minegishi as Chief Financial Officer
Seasoned biotech executive with a track record of guiding corporate development, financial strategy and commercialization for public and private biopharma companies Seasoned biotech executive with a track record of guiding corporate development, financial strategy and commercialization for public and private biopharma companiesVivek Ramaswamy's brother Shankar raises $1.2 billion for gene therapy firm with no ...
US News: Kriya Therapeutics, a gene therapy company founded in 2019 by Shankar Ramaswamy, brother of GOP leader Vivek Ramaswamy, has raised more than $1.2 bill.Kriya appoints Greg Di Russo, MD as Chief Medical Officer
Accomplished biopharma executive with deep experience leading the development of complex biologics and gene therapies at multiple small and large biopharmaceutical companies Accomplished biopharma executive with deep experience leading the development of complex biologics and gene therapies at multiple small and large biopharmaceutical companiesKriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need
– Proceeds to support clinical trials of Kriya’s five lead pipeline programs, as well as the Company’s R&D and manufacturing engine for new product development – – Proceeds to support clinical trials of Kriya’s five lead pipeline programs, as well as the Company’s R&D and manufacturing engine for new product development –
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kriya Therapeutics
Sign Up For FreeTo access detailed company insights
Kriya Therapeutics is a biopharmaceutical company focused on research and development of innovative gene therapies for prevalent diseases, supported by an in-house manufacturing facility to ensure scalable and cost-effective production.... Read More
